Publikationen in Zusammenarbeit mit Forschern von Universitat de Barcelona (15)

2024

  1. Predictive capacity for local disease control of neogenin-1 (NEO1) transcriptional expression in patients with head and neck squamous cell carcinoma

    Clinical and Translational Oncology

  2. The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma

    Breast Cancer Research, Vol. 26, Núm. 1

2022

  1. Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma

    Matrix Biology, Vol. 111, pp. 207-225

  2. Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC

    Cancers, Vol. 14, Núm. 9

  3. Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment

    Journal of Clinical Investigation, Vol. 132, Núm. 7

2021

  1. Cancer-associated fibroblasts in breast cancer treatment response and metastasis

    Cancers, Vol. 13, Núm. 13

2020

  1. Breast mammographic density: Stromal implications on breast cancer detection and therapy

    Journal of Clinical Medicine, Vol. 9, Núm. 3

  2. Epigenetic SmAd3 repression in tumor-associated fibroblasts impairs fibrosis and response to the antifibrotic drug nintedanib in lung squamous cell carcinoma

    Cancer Research, Vol. 80, Núm. 2, pp. 276-290

  3. The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer

    International Journal of Cancer, Vol. 147, Núm. 4, pp. 1163-1179

  4. Tumor-associated fibroblasts promote HER2-targeted therapy resistance through FGFR2 activation

    Clinical Cancer Research, Vol. 26, Núm. 6, pp. 1432-1448

  5. Unraveling the role of fibroblasts, FGF5 and FGFR2 in HER2- targeted therapies resistance and tumor progression

    Oncotarget, Vol. 11, Núm. 33, pp. 4541-4543

2018

  1. Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis

    Breast Cancer Research, Vol. 20, Núm. 1

  2. Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer

    Cancer Letters, Vol. 424, pp. 70-83

2016

  1. Differential expression of neurogenes among breast cancer subtypes identifies high risk patients

    Oncotarget, Vol. 7, Núm. 5, pp. 5313-5326

  2. The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase

    Clinical Cancer Research, Vol. 22, Núm. 10, pp. 2508-2519